Conversion to Neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life.
Tolba
R H
RH
Division of Surgical Research, Department of Surgery, University of Bonn, Bonn, Germany.
Wrigge
B
B
Machein
U
U
Minor
T
T
Kalff
J C
JC
Hirner
A
A
Wolff
M
M
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004644:Emotions; D005260:Female; D006304:Health Status; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D016031:Liver Transplantation / Q000502:physiology* / Q000523:psychology*; D008297:Male; D008603:Mental Health; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010146:Pain; D011788:Quality of Life; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone